GB1507216A - Immunoregulatory preparation - Google Patents
Immunoregulatory preparationInfo
- Publication number
- GB1507216A GB1507216A GB1514977A GB1514977A GB1507216A GB 1507216 A GB1507216 A GB 1507216A GB 1514977 A GB1514977 A GB 1514977A GB 1514977 A GB1514977 A GB 1514977A GB 1507216 A GB1507216 A GB 1507216A
- Authority
- GB
- United Kingdom
- Prior art keywords
- blood
- globulin
- preparation
- fraction
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
Abstract
1507216 α - globulin preparation GREEN CROSS CORP 19 Aug 1975 15149/77 Divided out of 1507215 Heading A5B [Also in Division C3] Immunoregulators derived from human blood or a fraction thereof contain immunoregulatory α - globulin, the blood or fraction thereof containing α 2 - globulin and having been subjected to liepatitis virus (HB - Ag) inactivation treatment and having a content of substances capable of producing decreased blood pressure in an adult dog to the extent of no more than 7.5% at a dosage of 40 mg/kg body weight. The preparation may be in the form of a powder or injeotable solution. They may be derived from placental blood or .blood plasma. They may be prepared by the process claimed in Parent Specification No.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1514977A GB1507216A (en) | 1975-08-19 | 1975-08-19 | Immunoregulatory preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1514977A GB1507216A (en) | 1975-08-19 | 1975-08-19 | Immunoregulatory preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1507216A true GB1507216A (en) | 1978-04-12 |
Family
ID=10053913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1514977A Expired GB1507216A (en) | 1975-08-19 | 1975-08-19 | Immunoregulatory preparation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1507216A (en) |
-
1975
- 1975-08-19 GB GB1514977A patent/GB1507216A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES461918A1 (en) | Method of producing a blood-coagulation-promoting preparation from human blood plasma | |
DE3170119D1 (en) | Product in powder form for the treatment of wounds, and method for the preparation thereof | |
EP0136011A3 (en) | A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor | |
ES427573A1 (en) | Nitrogen-containing compounds | |
IE41064B1 (en) | Peptides having lh-rh/fsh-rh activity and process for preparing them | |
PT66789A (en) | Process for the preparation of pharmaceutical compositions having high rate of resorption,from heart glicosides,in se hardly resorptive,to be parenterically administered | |
DE3062981D1 (en) | Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives | |
AU573262B2 (en) | Covalently bound heparin-antithrombin iii complex | |
ES8503643A1 (en) | Biscarboxamides for treating diseases, and process for their preparation. | |
AU5268879A (en) | Analgesic tablet | |
IL88971A0 (en) | Disubstituted pyridines,their preparation and pharmaceutical compositions containing them | |
IE40267L (en) | Alkanolamine derivatives | |
ES428338A1 (en) | Method for treating cardiovascular circulatory insufficiencies and hypotonia with 2-hydroxy-phenyl-1-oxa-4-azaspiroalkane derivatives | |
GB1507216A (en) | Immunoregulatory preparation | |
HU9201799D0 (en) | New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments | |
JPS51118820A (en) | A process for preparing heat stable macroglobulin | |
DE3268159D1 (en) | Medicaments based on algae, and formulations thereof | |
JPS6471814A (en) | Useikokashooshochisurutamenoiyakusoseibutsu | |
IL66757A0 (en) | 3-phenoxypropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them | |
JPS5679622A (en) | Antitumor pharmaceutical | |
DE3362045D1 (en) | Aqueous solution of ursodeoxycholic acid for therapeutic uses, process for its preparation and its utilization for the treatment of cholelithiasis | |
CA2255856A1 (en) | Therapeutic uses for an aminosterol compound | |
GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
DE2962886D1 (en) | Derivatives of l-cysteine, their use as medicaments and process for their preparation | |
IE39053L (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |